Novel compound heterozygous variants of TBXAS1 presenting with Ghosal hematodiaphyseal dysplasia treated with steroids
Abstract Background Homozygous or compound heterozygous pathogenic variants in the thromboxane A synthase 1 (TBXAS1) gene are associated with Ghosal hematodiaphyseal dysplasia (GHDD) which is characterized by defective hematopoiesis and increased bone density of long bones. Methods Patients 1 and 2...
Main Authors: | Sun Young Kim, Alexander Ing, Shunyou Gong, Kai Lee Yap, Rukhmi Bhat |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-03-01
|
Series: | Molecular Genetics & Genomic Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/mgg3.1494 |
Similar Items
-
Ghosal Hematodiaphyseal Dysplasia: A Case Report
by: Marjan Shakiba, et al.
Published: (2020-04-01) -
Ghosal hematodiaphyseal dysplasia – A remediable cause of refractory anemia: A case report
by: Vaishnavi Sreenivasan, et al.
Published: (2023-12-01) -
Ghosal hematodiaphyseal dysplasia (GHDD) diagnosis and treatment: case report
by: Gular MAMMADOVA, et al.
Published: (2022-10-01) -
A GHOSAL HEMATODIAPHYSEAL DYSPLASIA CASE; EXCELLENT RESPONSE TO NON-STEROIDAL ANTI-INFLAMATORY DRUG TREATMENT
by: Hasan Fatih Cakmaklı, et al.
Published: (2023-10-01) -
Eicosanoids in the Pancreatic Tumor Microenvironment—A Multicellular, Multifaceted Progression
by: Vikas B. Gubbala, et al.
Published: (2022-01-01)